In addition, we also found that RFX1 expression level was negatively correlated with serum C-reactive protein (CRP) level, a surrogate marker of IL-6 activity, in SLE patients with active arthritis (Supplementary Fig. 9). Here, RFX1 is linked to systemic lupus erythematosus.